2022 Revenues ($USD) : $2,970,336,391
2022 Revenues (foreign currencies) : DKK kr19,426,000,000
2022 R&D spend : $115,443,425
2022 Number of Employees : 12,578
Fiscal Year End : 9/30/2021
Company CEO : Kristian Villumsen, president & CEO

Humlebaek, Denmark–based Coloplast specializes in the development of ostomy, continence, interventional urology, wound and skin care products and services. The company bills itself as a leader in “intimate healthcare needs.” The international company has about 14,000 employees. In June, Coloplast won an AscenDrive agreement with Premier. The AscenDrive program standardizes the care delivery process. The company is one of two suppliers awarded the AscenDrive contract for ostomy products. In July 2022, a federal judge in Minnesota granted summary judgment to Coloplast in a transvaginal mesh lawsuit. –BB

*The 2022 Big 100 report is moving to September versus November in previous years. Because its fiscal year ends in September, Coloplast's revenue number is the same as in the 2021 report.